Advertisement
Canada markets open in 3 hours 2 minutes

  • S&P/TSX

    21,728.55
    +14.01 (+0.06%)
     

  • S&P 500

    5,018.39
    -17.30 (-0.34%)
     

  • DOW

    37,903.29
    +87.37 (+0.23%)
     

  • CAD/USD

    0.7287
    +0.0006 (+0.08%)
     

  • CRUDE OIL

    79.53
    +0.53 (+0.67%)
     

  • Bitcoin CAD

    79,186.05
    +600.79 (+0.76%)
     

  • CMC Crypto 200

    1,248.54
    -22.21 (-1.75%)
     

  • GOLD FUTURES

    2,307.00
    -4.00 (-0.17%)
     

  • RUSSELL 2000

    1,980.23
    +6.32 (+0.32%)
     

  • 10-Yr Bond

    4.5950
    -0.0910 (-1.94%)
     

  • NASDAQ futures

    17,583.25
    +145.00 (+0.83%)
     

  • VOLATILITY

    14.98
    -0.41 (-2.66%)
     

  • FTSE

    8,149.76
    +28.52 (+0.35%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • CAD/EUR

    0.6808
    +0.0015 (+0.22%)
     

Ionis to present at upcoming investor conferences

PR Newswire
·1 min read

CARLSBAD, Calif., April 1, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)
Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)

  • 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024

  • 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024

  • BofA Securities Health Care Conference 2024 on Tuesday, May 14, 2024

  • 45th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 12, 2024

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionispharma.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

ADVERTISEMENT

About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionispharma.com and follow us on X (Twitter) and LinkedIn.

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-302102970.html

SOURCE Ionis Pharmaceuticals, Inc.